Benjamin G. Vincent

Department of Microbiology and Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
"Benjamin Vincent"


Sign in to add mentor
Jeffrey A. Frelinger post-doc UNC Chapel Hill (Microtree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Routh ED, Woodcock MG, Beckabir W, et al. (2023) Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal For Immunotherapy of Cancer. 11
Olsen KS, Jadi O, Dexheimer S, et al. (2022) Shared graft-vs-leukemia minor histocompatibility antigens in DISCOVeRY-BMT. Blood Advances
Li S, Mirlekar B, Johnson BM, et al. (2022) STING-induced regulatory B cells compromise NK function in cancer immunity. Nature
Mirlekar B, Wang Y, Li S, et al. (2022) Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity. Cell Reports. Medicine. 3: 100744
Chai S, Smith CC, Kochar TK, et al. (2022) NeoSplice: a bioinformatics method for prediction of splice variant neoantigens. Bioinformatics Advances. 2: vbac032
Nishijima TF, Kardos J, Chai S, et al. (2022) Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer. Jco Precision Oncology. 1: 1-10
Anders CK, Woodcock MG, Van Swearingen AED, et al. (2022) Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal For Immunotherapy of Cancer. 10
Downs-Canner SM, Meier J, Vincent BG, et al. (2022) B Cell Function in the Tumor Microenvironment. Annual Review of Immunology
Zeidner JF, Vincent BG, Ivanova A, et al. (2021) Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Blood Cancer Discovery. 2: 616-629
Tschernia NP, Kumar V, Moore DT, et al. (2021) Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplant in Acute Myeloid Leukemia. Transplantation and Cellular Therapy
See more...